primary antibodies 184 against igf1r (Affinity Biosciences)
86
Structured Review
Affinity Biosciences
primary antibodies 184 against igf1r
Primary Antibodies 184 Against Igf1r, supplied by Affinity Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+184+against+igf1r/15+anti+factor+klf15+kruppel+like/10__2139_slash_ssrn__4181417-87-0-7
Average 86 stars, based on 1 article reviews
Primary Antibodies 184 Against Igf1r, supplied by Affinity Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+184+against+igf1r/15+anti+factor+klf15+kruppel+like/10__2139_slash_ssrn__4181417-87-0-7
Average 86 stars, based on 1 article reviews
primary antibodies 184 against igf1r - by Bioz Stars,
2026-11
86/100 stars
Images
Related Articles
other:Article Title: Overexpression of miR-297b-5p Promotes Metformin-Mediated Protection Against Stearic Acid-Induced Senescence by Targeting Igf1r Article Snippet: 2 acid-induced senescence by targeting Igf1r 3 Running title: miR-297b-5p in SA-induced β cell senescence 4 Qingrui Zhao1#, Shenghan Su1#, Yuqing Lin1, Xuebei Li1, Lingfeng Dan1, Yunjin Zhang1, 5 Chunxiao Yang1, Xiaohan Li1, Yimeng Dong1, Chenchen Geng1, Changhao Sun1, Xia Chu1*, 6 Huimin Lu1* 7 1Department of Nutrition and Food Hygiene (National Key Discipline), Public Health College, 8 Harbin Medical University, Harbin, China.. 9 Address: Department of Nutrition and Food Hygiene, Public Health College, Harbin Medical 10 University, 157 Baojian Road, Nangang District, Harbin, Hei Longjiang province, 150081, 11 People’s Republic of China.. 12 Fax: +86-451-87502885 Tel: +86-451-87502837 13 *Corresponding authors: Huimin Lu, lhm_519@sina.com and Xia Chu, cx831128@163.com 14 # These authors contributed equally to this work 15 Other authors: Qingrui Zhao, 46202278@qq.com; Shenghan Su, 1403545022@qq.com; 16 Yuqing Lin, 1024770609@qq.com; Xuebei Li, 3067955962@qq.com; Lingfeng Dan, 17 1115120367@qq.com; Yunjin Zhang, 1484336529@qq.com; Chunxiao Yang, |